Search results

Representation and inclusion of various minority groups is crucial for medical research. Discover how drug developers, researchers, and regulators are ensuring this happens.

Altasciences determines the suitability of nano milling for a client’s highly active compound with very poor aqueous solubility and less than desirable bioavailability.

A leading developer of novel cancer therapeutics was experiencing persistent manufacturing process issues. Our engineers were able to diagnose and solve two problems.

Learn 5 practical strategies to reduce AI hallucination in clinical research to improve accuracy, transparency, compliance, and decision-making.

The 2025 Year in Review highlights 30 years of drug development expertise, key milestones, events, resources, and innovations shaping early-phase research.